152 related articles for article (PubMed ID: 15534031)
1. Hallucinations with tolterodine.
Williams SG; Staudenmeier J
Psychiatr Serv; 2004 Nov; 55(11):1318-9. PubMed ID: 15534031
[No Abstract] [Full Text] [Related]
2. Tolterodine.
Nurs Times; 2006 Jun 6-12; 102(23):27. PubMed ID: 16784047
[No Abstract] [Full Text] [Related]
3. Safety and tolerability of tolterodine for the treatment of overactive bladder in adults.
Roberts RG; Garely AD; Bavendam T
Am J Manag Care; 2005 Jul; 11(4 Suppl):S158-62. PubMed ID: 16161389
[TBL] [Abstract][Full Text] [Related]
4. Transient memory impairment and hallucinations associated with tolterodine use.
Tsao JW; Heilman KM
N Engl J Med; 2003 Dec; 349(23):2274-5. PubMed ID: 14657444
[No Abstract] [Full Text] [Related]
5. [Overactive bladder. New anticholinergic drug controls urinary urge].
MMW Fortschr Med; 2004 Jul; 146(27-28):51. PubMed ID: 15526670
[No Abstract] [Full Text] [Related]
6. The newer antimuscarinic drugs: bladder control with less dry mouth.
Appell RA
Cleve Clin J Med; 2002 Oct; 69(10):761, 765-6, 768-9. PubMed ID: 12371799
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of mixed urinary incontinence].
Goepel M
Urologe A; 2003 Jun; 42(6):812-7. PubMed ID: 12851773
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder.
Armstrong RB; Luber KM; Peters KM
Int Urol Nephrol; 2005; 37(2):247-52. PubMed ID: 16142551
[TBL] [Abstract][Full Text] [Related]
9. Visual hallucinations at the onset of tolterodine treatment in a patient with a high-level spinal cord injury.
Malavaud B; Bagheri H; Senard JM; Sarramon JP
BJU Int; 1999 Dec; 84(9):1109. PubMed ID: 10571650
[No Abstract] [Full Text] [Related]
10. Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005;48:464-70.
Jonas U; Rackley RR
Eur Urol; 2006 Jan; 49(1):187-8; author reply 188-90. PubMed ID: 16310930
[No Abstract] [Full Text] [Related]
11. Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/over active bladder: a systematic review.
Medhi B; Mittal N; Bansal D; Prakash A; Sarangi SC; Nirthi B
Indian J Physiol Pharmacol; 2013; 57(4):343-53. PubMed ID: 24968572
[TBL] [Abstract][Full Text] [Related]
12. Re: safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
Schaefer W
J Urol; 2006 Nov; 176(5):2311-2; author reply 2312-3. PubMed ID: 17070326
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.
Ethans KD; Nance PW; Bard RJ; Casey AR; Schryvers OI
J Spinal Cord Med; 2004; 27(3):214-8. PubMed ID: 15478523
[TBL] [Abstract][Full Text] [Related]
14. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
[TBL] [Abstract][Full Text] [Related]
15. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.
Edwards KR; O'Connor JT
J Am Geriatr Soc; 2002 Jun; 50(6):1165-6. PubMed ID: 12110086
[No Abstract] [Full Text] [Related]
16. Tolterodine once-daily in treatment of the overactive bladder.
Peters KM; Huang RR
Urology; 2001 Nov; 58(5):829-32. PubMed ID: 11711378
[No Abstract] [Full Text] [Related]
17. Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
Staskin DR; Dmochowski RR; Wein AJ
Curr Urol Rep; 2005 Nov; 6(6):403-4. PubMed ID: 16238911
[No Abstract] [Full Text] [Related]
18. Syndrome of inappropriate antidiuretic hormone associated with tolterodine therapy.
Bryan MK; Nguyen MT; Hilas O
Consult Pharm; 2010 May; 25(5):320-2. PubMed ID: 20497930
[TBL] [Abstract][Full Text] [Related]
19. Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity--a comment.
Short DD
Pharmacotherapy; 1999 Oct; 19(10):1188. PubMed ID: 10512072
[No Abstract] [Full Text] [Related]
20. [A drug seeks its disease].
Löfgren O
Lakartidningen; 2010 Jun 2-8; 107(22):1488-9. PubMed ID: 20645604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
